-
2
-
-
34247379134
-
Molecular positron emission tomography and PET/CT imaging in urological malignancies
-
Powels T, Murray I, Brock C, Oliver T and Avril N: Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol 51: 1520-1521, 2007.
-
(2007)
Eur Urol
, vol.51
, pp. 1520-1521
-
-
Powels, T.1
Murray, I.2
Brock, C.3
Oliver, T.4
Avril, N.5
-
3
-
-
33645731918
-
Positron emission tomography and molecular imaging of the prostate: An update
-
Lawrentschuk N, Davis ID, Bolton DM and Scott AM: Positron emission tomography and molecular imaging of the prostate: an update. BJU Int 97: 923-931, 2006.
-
(2006)
BJU Int
, vol.97
, pp. 923-931
-
-
Lawrentschuk, N.1
Davis, I.D.2
Bolton, D.M.3
Scott, A.M.4
-
4
-
-
0030061905
-
Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose
-
Effert PJ, Bares R, Handt S, Wolff JM, Büll U and Jakse G: Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol 155: 994-998, 1996.
-
(1996)
J Urol
, vol.155
, pp. 994-998
-
-
Effert, P.J.1
Bares, R.2
Handt, S.3
Wolff, J.M.4
Büll, U.5
Jakse, G.6
-
6
-
-
77952680832
-
Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy
-
Liu Y, Ghesani NV and Zuckier LS: Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy. Semin Nucl Med 40: 294-315, 2010.
-
(2010)
Semin Nucl Med
, vol.40
, pp. 294-315
-
-
Liu, Y.1
Ghesani, N.V.2
Zuckier, L.S.3
-
7
-
-
0032993484
-
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy
-
Hofer C, Laubenbacher C, Block T, Breul J, Hartung R and Schwaiger M: Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol 36: 31-35, 1999.
-
(1999)
Eur Urol
, vol.36
, pp. 31-35
-
-
Hofer, C.1
Laubenbacher, C.2
Block, T.3
Breul, J.4
Hartung, R.5
Schwaiger, M.6
-
8
-
-
0033253147
-
The increased accumulation of [18F]-fluorodeoxyglucose in untreated prostate cancer
-
Oyama N, Akino H, Suzuki Y, Kanamaru H, Sadato N, Yonekura Y and Okada K: The increased accumulation of [18F]-fluorodeoxyglucose in untreated prostate cancer. Jpn J Clin Oncol 29: 623-629, 1999.
-
(1999)
Jpn J Clin Oncol
, vol.29
, pp. 623-629
-
-
Oyama, N.1
Akino, H.2
Suzuki, Y.3
Kanamaru, H.4
Sadato, N.5
Yonekura, Y.6
Okada, K.7
-
9
-
-
0035154742
-
Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer
-
Liu IJ, Zafar MB, Lai YH, Segall GM and Terris MK: Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology 57:108-111, 2001.
-
(2001)
Urology
, vol.57
, pp. 108-111
-
-
Liu, I.J.1
Zafar, M.B.2
Lai, Y.H.3
Segall, G.M.4
Terris, M.K.5
-
10
-
-
78751584772
-
The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level
-
Minamimoto R, Uemura H, Sano F, Terao H, Nagashima Y, Yamanaka S, Shizukuishi K, Tateishi U, Kubota Y and Inoue T: The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level. Ann Nucl Med 25: 21-27, 2011.
-
(2011)
Ann Nucl Med
, vol.25
, pp. 21-27
-
-
Minamimoto, R.1
Uemura, H.2
Sano, F.3
Terao, H.4
Nagashima, Y.5
Yamanaka, S.6
Shizukuishi, K.7
Tateishi, U.8
Kubota, Y.9
Inoue, T.10
-
11
-
-
0344839033
-
Expression and localization of GLUT1 and GLUT12 in prostate carcinoma
-
Candler JD, Williams ED, Slavin JL, Best JD and Rogers S: Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 97: 2035-2042, 2003.
-
(2003)
Cancer
, vol.97
, pp. 2035-2042
-
-
Candler, J.D.1
Williams, E.D.2
Slavin, J.L.3
Best, J.D.4
Rogers, S.5
-
13
-
-
77950546594
-
Dominant uptake of fatty acid over glucose by prostate cells: A potential new diagnostic and therapeutic approach
-
Liu Y, Zuckier LS and Ghesani NV: Dominant uptake of fatty acid over glucose by prostate cells: a potential new diagnostic and therapeutic approach. Anticancer Res 30: 369-374, 2010.
-
(2010)
Anticancer Res
, vol.30
, pp. 369-374
-
-
Liu, Y.1
Zuckier, L.S.2
Ghesani, N.V.3
-
14
-
-
0032722534
-
Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose
-
Heicappell R, Müller-Mattheis V, Reinhardt M, Vosberg H, Gerharz CD, Müller-Gärtner H and Ackermann R: Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol 36: 582-587, 1999.
-
(1999)
Eur Urol
, vol.36
, pp. 582-587
-
-
Heicappell, R.1
Müller-Mattheis, V.2
Reinhardt, M.3
Vosberg, H.4
Gerharz, C.D.5
Müller-Gärtner, H.6
Ackermann, R.7
-
15
-
-
0038639067
-
Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer
-
Chang CH, Wu HC, Tsai JJ, Shen YY, Changlai SP and Kao A: Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer. Urol Int 70: 311-315, 2003.
-
(2003)
Urol Int
, vol.70
, pp. 311-315
-
-
Chang, C.H.1
Wu, H.C.2
Tsai, J.J.3
Shen, Y.Y.4
Changlai, S.P.5
Kao, A.6
-
16
-
-
27644562208
-
2-[18F]fluororo-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostatic-specific antigen relapse after radical prostatectomy
-
Schöder H, Herrmann K, Gönen M, Hricak H, Eberhard S, Scardino P, Scher HI and Larson SM: 2-[18F]fluororo-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostatic-specific antigen relapse after radical prostatectomy. Clin Cancer Res 11: 4761-4769, 2005.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4761-4769
-
-
Schöder, H.1
Herrmann, K.2
Gönen, M.3
Hricak, H.4
Eberhard, S.5
Scardino, P.6
Scher, H.I.7
Larson, S.M.8
-
17
-
-
6444226036
-
Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma
-
Effert P, Beniers AJ, Tamimi Y, Hardt S and Jakse G: Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma. Anticancer Res 24: 3057-3063, 2004.
-
(2004)
Anticancer Res
, vol.24
, pp. 3057-3063
-
-
Effert, P.1
Beniers, A.J.2
Tamimi, Y.3
Hardt, S.4
Jakse, G.5
-
18
-
-
84858708382
-
Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT
-
Shiiba M, Ishihara K, Kimura G, Kuwako T, Yoshihara H, Sato H, Kondo Y, Tsuchiya S and Kumita S: Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT. Ann Nucl Med 26: 138-145, 2012.
-
(2012)
Ann Nucl Med
, vol.26
, pp. 138-145
-
-
Shiiba, M.1
Ishihara, K.2
Kimura, G.3
Kuwako, T.4
Yoshihara, H.5
Sato, H.6
Kondo, Y.7
Tsuchiya, S.8
Kumita, S.9
-
19
-
-
79956320551
-
Prostate cancer
-
Jadvar H: Prostate cancer. Methods Mol Biol 727: 265-290, 2011.
-
(2011)
Methods Mol Biol
, vol.727
, pp. 265-290
-
-
Jadvar, H.1
-
20
-
-
78649425873
-
PET/CT imaging and radioimmunotherapy of prostate cancer
-
Bouchelouche K, Tagawa ST, Glodsmith SJ, Turkbey B, Capala J and Choyke P: PET/CT imaging and radioimmunotherapy of prostate cancer. Semin Nucl Med 41: 29-44, 2011.
-
(2011)
Semin Nucl Med
, vol.41
, pp. 29-44
-
-
Bouchelouche, K.1
Tagawa, S.T.2
Glodsmith, S.J.3
Turkbey, B.4
Capala, J.5
Choyke, P.6
|